TTA-A8

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameTTA-A8
Drug Alias NameT-type calcium channel antagonists, Merck & CoTTA-P2TTA-A2TTA-A8
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVoltage-gated T-type calcium channel blockers
TargetsVoltage-gated T-type calcium channel
Therapy Area/IndicationsTobacco Use DisorderHeadacheSleep Initiation and Maintenance Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Sharp & Dohme Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Sharp & Dohme Corp
Active IndicationsN/A
Inactive IndicationsTobacco Use DisorderHeadacheSleep Initiation and Maintenance Disorders

Other Information

ATC CodeN/A
Related LinksN/A